S&P 500   4,769.83
DOW   37,689.54
QQQ   409.52
US Navy helicopters fire at Yemen's Houthi rebels and kill several in latest Red Sea shipping attack
New Year's Sale: Get 12 Months of Stock Picks for $9.00 (Ad)
A lithium-ion battery fire in a cargo ship's hold is out after several days of burning
Chief Justice Roberts casts a wary eye on the uses of artificial intelligence in the federal courts
MarketBeat All Access New Year's Sale - Just $1.00 (Ad)
S&P 500   4,769.83
DOW   37,689.54
QQQ   409.52
US Navy helicopters fire at Yemen's Houthi rebels and kill several in latest Red Sea shipping attack
New Year's Sale: Get 12 Months of Stock Picks for $9.00 (Ad)
A lithium-ion battery fire in a cargo ship's hold is out after several days of burning
Chief Justice Roberts casts a wary eye on the uses of artificial intelligence in the federal courts
MarketBeat All Access New Year's Sale - Just $1.00 (Ad)
S&P 500   4,769.83
DOW   37,689.54
QQQ   409.52
US Navy helicopters fire at Yemen's Houthi rebels and kill several in latest Red Sea shipping attack
New Year's Sale: Get 12 Months of Stock Picks for $9.00 (Ad)
A lithium-ion battery fire in a cargo ship's hold is out after several days of burning
Chief Justice Roberts casts a wary eye on the uses of artificial intelligence in the federal courts
MarketBeat All Access New Year's Sale - Just $1.00 (Ad)
S&P 500   4,769.83
DOW   37,689.54
QQQ   409.52
US Navy helicopters fire at Yemen's Houthi rebels and kill several in latest Red Sea shipping attack
New Year's Sale: Get 12 Months of Stock Picks for $9.00 (Ad)
A lithium-ion battery fire in a cargo ship's hold is out after several days of burning
Chief Justice Roberts casts a wary eye on the uses of artificial intelligence in the federal courts
MarketBeat All Access New Year's Sale - Just $1.00 (Ad)
NYSE:RVTY

Revvity (RVTY) Stock Price, News & Analysis

$109.31
-1.46 (-1.32%)
(As of 12/29/2023 ET)
Today's Range
$108.88
$111.26
50-Day Range
$82.09
$110.79
52-Week Range
$79.50
$145.35
Volume
385,098 shs
Average Volume
884,963 shs
Market Capitalization
$13.49 billion
P/E Ratio
18.37
Dividend Yield
0.26%
Price Target
$115.75

Revvity MarketRank™ Stock Analysis

Analyst Rating
Moderate Buy
2.56 Rating Score
Upside/​Downside
5.9% Upside
$115.75 Price Target
Short Interest
N/A
Dividend Strength
Weak
Based on Four Factors
Sustainability
N/A
News Sentiment
0.47mentions of Revvity in the last 14 days
Based on 2 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
N/A

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.82 out of 5 stars

Medical Sector

751st out of 950 stocks

Analytical Instruments Industry

19th out of 26 stocks


RVTY stock logo

About Revvity Stock (NYSE:RVTY)

Revvity, Inc. provides products, services, and solutions to the diagnostics, life sciences, and applied services markets worldwide. It operates through two segments, Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection, and imaging technologies that enable scientists to enhance research breakthroughs in the life sciences research market, as well as contract research and laboratory services. It also provides analytical technologies, solutions, and services for its customers to understand the characterize the health of various aspects, including air, water, and soil. In addition, this segment offers solutions to farmers and food producers; and analytical instrumentation for the industrial market, which includes the chemical, semiconductor and electronics, energy, lubricant, petrochemical, and polymer industries. The Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market. Its products are used for testing and screening genetic abnormalities, disorders, and diseases, including down syndrome, hypothyroidism, muscular dystrophy, infertility, and various metabolic conditions. This segment also develops technologies that enable and support genomic workflows using protein coupled receptor and next-generation DNA sequencing for applications in oncology, immunodiagnostics, and drug discovery. It serves pharmaceutical and biotechnology companies, laboratories, academic and research institutions, public health authorities, private healthcare organizations, doctors, and government agencies. The company was formerly known as PerkinElmer, Inc. and changed its name to Revvity, Inc. in April 2023. Revvity, Inc. was founded in 1937 and is headquartered in Waltham, Massachusetts.

RVTY Stock Price History

RVTY Stock News Headlines

FINAL OFFER: $9 for a FULL YEAR of stock picks
We're offering you the chance to subscribe to Behind the Markets for an ENTIRE YEAR for just $9. That's less than a cup of coffee! And what do you get for that $9?
Revvity, Inc. Common Stock (RVTY)
Revvity to Present at J.P. Morgan Healthcare Conference
7 Analysts Have This to Say About Revvity
New Year's Sale: Get MarketBeat All Access Free For 30 Days
Access our premier research platform that includes MarketBeat Daily Premium, portfolio monitoring tools, stock screeners, research tools, a real-time news feed, email and SMS alerts, the MarketBeat Idea Engine, proprietary brokerage rankings, extended data export tools and much more. Click the link to claim your $300.00 account credit and free 30-day subscription
Company News for Oct 31, 2023
Why Revvity Stock Plunged Today
Revvity (RVTY) Misses on Q3 Earnings, Lowers '23 EPS View
Revvity: Q3 Earnings Snapshot
Revvity, Inc. Announces Fall In Q3 Bottom Line, misses estimates
See More Headlines
Receive RVTY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Revvity and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Ex-Dividend for 11/10 Dividend
10/19/2023
Last Earnings
10/30/2023
Dividend Payable
11/10/2023
Today
12/31/2023
Fiscal Year End
12/31/2023
Ex-Dividend for 2/9 Dividend
1/18/2024
Dividend Payable
2/09/2024
Next Earnings (Estimated)
2/13/2024

Industry, Sector and Symbol

Industry
Analytical instruments
Sub-Industry
N/A
Sector
Medical
Employees
16,700
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$115.75
High Stock Price Target
$147.00
Low Stock Price Target
$95.00
Potential Upside/Downside
+5.9%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.56
Research Coverage
9 Analysts

Profitability

Net Income
$569.18 million
Pretax Margin
10.37%

Debt

Sales & Book Value

Annual Sales
$2.80 billion
Cash Flow
$11.77 per share
Book Value
$58.49 per share

Miscellaneous

Free Float
122,765,000
Market Cap
$13.49 billion
Optionable
Optionable
Beta
1.09
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Key Executives

  • Dr. Prahlad R. Singh Ph.D. (Age 58)
    CEO, President & Director
    Comp: $3.23M
  • Mr. Maxwell Krakowiak (Age 33)
    Senior VP & CFO
    Comp: $814.58k
  • Mr. Tajinder Vohra (Age 57)
    Senior Vice President of Global Operations
    Comp: $927.24k
  • Mr. Joel S. Goldberg (Age 54)
    Senior VP of Administration, General Counsel & Secretary
    Comp: $1.29M
  • Mr. Daniel R. Tereau (Age 55)
    Senior Vice President of Strategy & Business Development
    Comp: $967.97k
  • Mr. Andrew Okun (Age 53)
    VP, Chief Accounting Officer & Treasurer














RVTY Stock Analysis - Frequently Asked Questions

Should I buy or sell Revvity stock right now?

9 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Revvity in the last twelve months. There are currently 4 hold ratings and 5 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" RVTY shares.
View RVTY analyst ratings
or view top-rated stocks.

What is Revvity's stock price target for 2024?

9 brokerages have issued 12-month price objectives for Revvity's shares. Their RVTY share price targets range from $95.00 to $147.00. On average, they predict the company's share price to reach $115.75 in the next twelve months. This suggests a possible upside of 5.9% from the stock's current price.
View analysts price targets for RVTY
or view top-rated stocks among Wall Street analysts.

How have RVTY shares performed in 2023?

Revvity's stock was trading at $116.84 at the beginning of 2023. Since then, RVTY stock has decreased by 6.4% and is now trading at $109.31.
View the best growth stocks for 2023 here
.

When is Revvity's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, February 13th 2024.
View our RVTY earnings forecast
.

How were Revvity's earnings last quarter?

Revvity, Inc. (NYSE:RVTY) posted its quarterly earnings data on Monday, October, 30th. The company reported $1.18 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.19 by $0.01. The business had revenue of $670.30 million for the quarter, compared to analyst estimates of $695.40 million. Revvity had a net margin of 26.90% and a trailing twelve-month return on equity of 8.30%. The firm's revenue was down 5.9% on a year-over-year basis. During the same period in the previous year, the firm earned $1.51 earnings per share.

How often does Revvity pay dividends? What is the dividend yield for Revvity?

Revvity declared a quarterly dividend on Thursday, October 26th. Investors of record on Friday, January 19th will be given a dividend of $0.07 per share on Friday, February 9th. This represents a $0.28 annualized dividend and a dividend yield of 0.26%. The ex-dividend date of this dividend is Thursday, January 18th.
Read our dividend analysis for RVTY
.

Is Revvity a good dividend stock?

Revvity (NYSE:RVTY) pays an annual dividend of $0.28 per share and currently has a dividend yield of 0.25%. The dividend payout ratio is 4.71%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, RVTY will have a dividend payout ratio of 6.17% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for RVTY.

How will Revvity's stock buyback program work?

Revvity declared that its board has authorized a share buyback program on Thursday, May 11th 2023, which authorizes the company to buyback $600,000,000.00 in shares, according to EventVestor. This buyback authorization authorizes the company to buy up to 5.9% of its shares through open market purchases. Shares buyback programs are often a sign that the company's management believes its shares are undervalued.

What guidance has Revvity issued on next quarter's earnings?

Revvity issued an update on its FY23 earnings guidance on Monday, October, 30th. The company provided earnings per share guidance of $4.53-4.57 for the period, compared to the consensus estimate of $4.78. The company issued revenue guidance of $2.72-2.74 billion, compared to the consensus revenue estimate of $2.83 billion.

How do I buy shares of Revvity?

Shares of RVTY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSE:RVTY) was last updated on 12/31/2023 by MarketBeat.com Staff

My Account -